No Data
IQVIA Holdings (NYSE:IQV) Sheds 4.7% This Week, as Yearly Returns Fall More in Line With Earnings Growth
Baird Adjusts IQVIA Holdings Price Target to $195 From $220, Maintains Neutral Rating
Truist Financial Maintains IQVIA Holdings(IQV.US) With Buy Rating
Truist Financial Remains a Buy on IQVIA Holdings (IQV)
Under Trump's tariff threats, a new "landscape" in the USA: stockpiling medicine!
According to several Company Executives in the Pharmaceutical industry and Logistics companies, due to concerns that the reciprocal tariffs announced by President Trump on April 2 may involve Pharmaceutical products from Europe, some Pharmaceutical companies are taking unusual measures to transport more drugs to the USA via Air Transportation; Two Pharmaceutical companies headquartered in Europe stated to the media this week that they have transported as many Pharmaceutical products to the USA as possible in recent weeks, and they have also learned that other Pharmaceutical companies are taking similar actions.
What Is IQVIA Holdings Inc.'s (NYSE:IQV) Share Price Doing?
